tiprankstipranks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
SABS
SAB Biotherapeutics
RESEARCH TOOLSreports
Want to see SABS full AI Analyst Report?

SAB Biotherapeutics (SABS) Revenue

328 Followers
StatisticsMarket CapRevenue

SAB Biotherapeutics Revenue

SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, SAB Biotherapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
―
Revenue/Employee
$0
Employees
63
Market Cap
$272.21M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―-1.32M-100.00%
Mar 31, 2025
1.32M-916.59K-40.94%
Dec 31, 2023
2.24M-21.66M-90.63%
Mar 31, 2023
23.90M-36.97M-60.73%
Dec 31, 2021
60.88M5.64M+10.21%
Dec 31, 2020
55.24M51.80M+1,504.82%
Dec 31, 2019
3.44M――